ICD-9-CM procedure code (retired)
99.29 — Injection or infusion of other therapeutic or prophylactic substance
About ICD-9-CM 99.29
99.29 is an ICD-9-CM procedure code for injection or infusion of other therapeutic or prophylactic substance. ICD-9-CM was retired for U.S. claims on October 1, 2015, when ICD-10-PCS took over.
The CMS General Equivalence Mappings translate it to 65 ICD-10-PCS codes, such as 3E013GC (Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach), 3E0333Z (Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach) and 3E033FZ (Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach). All of these are approximate matches, so review the record to pick the right one.
ICD-10-PCS equivalents
- 3E013GCIntroduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approachapproximate
- 3E0333ZIntroduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approachapproximate
- 3E033FZIntroduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approachapproximate
- 3E033HZIntroduction of Radioactive Substance into Peripheral Vein, Percutaneous Approachapproximate
- 3E033KZIntroduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approachapproximate
- 3E033RZIntroduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approachapproximate
- 3E033WKIntroduction of Immunostimulator into Peripheral Vein, Percutaneousapproximate
- 3E0433ZIntroduction of Anti-inflammatory into Central Vein, Percutaneous Approachapproximate
- 3E043FZIntroduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approachapproximate
- 3E043HZIntroduction of Radioactive Substance into Central Vein, Percutaneous Approachapproximate
- 3E043KZIntroduction of Other Diagnostic Substance into Central Vein, Percutaneous Approachapproximate
- 3E043RZIntroduction of Antiarrhythmic into Central Vein, Percutaneous Approachapproximate
- 3E043WKIntroduction of Immunostimulator into Central Vein, Percutaneousapproximate
- 3E050TZIntroduction of Destructive Agent into Peripheral Artery, Open Approachapproximate
- 3E0533ZIntroduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approachapproximate
- 3E053FZIntroduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approachapproximate
- 3E053HZIntroduction of Radioactive Substance into Peripheral Artery, Percutaneous Approachapproximate
- 3E053KZIntroduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approachapproximate
- 3E053RZIntroduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approachapproximate
- 3E053TZIntroduction of Destructive Agent into Peripheral Artery, Percutaneous Approachapproximate
- 3E053WKIntroduction of Immunostimulator into Peripheral Artery, Percutaneousapproximate
- 3E060TZIntroduction of Destructive Agent into Central Artery, Open Approachapproximate
- 3E0633ZIntroduction of Anti-inflammatory into Central Artery, Percutaneous Approachapproximate
- 3E063FZIntroduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approachapproximate
- 3E063HZIntroduction of Radioactive Substance into Central Artery, Percutaneous Approachapproximate
- 3E063RZIntroduction of Antiarrhythmic into Central Artery, Percutaneous Approachapproximate
- 3E063TZIntroduction of Destructive Agent into Central Artery, Percutaneous Approachapproximate
- 3E063WKIntroduction of Immunostimulator into Central Artery, Percutaneousapproximate
- 3E093GCIntroduction of Other Therapeutic Substance into Nose, Percutaneous Approachapproximate
- 3E093TZIntroduction of Destructive Agent into Nose, Percutaneous Approachapproximate
- 3E097GCIntroduction of Other Therapeutic Substance into Nose, Via Natural or Artificial Openingapproximate
- 3E097TZIntroduction of Destructive Agent into Nose, Via Natural or Artificial Openingapproximate
- 3E09XTZIntroduction of Destructive Agent into Nose, External Approachapproximate
- 3E0D3GCIntroduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approachapproximate
- 3E0D3TZIntroduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approachapproximate
- 3E0D7GCIntroduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Openingapproximate
- 3E0D7TZIntroduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Openingapproximate
- 3E0DXTZIntroduction of Destructive Agent into Mouth and Pharynx, External Approachapproximate
- 3E0G3TZIntroduction of Destructive Agent into Upper GI, Percutaneous Approachapproximate
- 3E0G7TZIntroduction of Destructive Agent into Upper GI, Via Natural or Artificial Openingapproximate
- 3E0G8TZIntroduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0H3GCIntroduction of Other Therapeutic Substance into Lower GI, Percutaneous Approachapproximate
- 3E0H3TZIntroduction of Destructive Agent into Lower GI, Percutaneous Approachapproximate
- 3E0H4GCIntroduction of Other Therapeutic Substance into Lower GI, Percutaneous Endoscopic Approachapproximate
- 3E0H7TZIntroduction of Destructive Agent into Lower GI, Via Natural or Artificial Openingapproximate
- 3E0H8TZIntroduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0K3TZIntroduction of Destructive Agent into Genitourinary Tract, Percutaneous Approachapproximate
- 3E0K7GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Openingapproximate
- 3E0K7TZIntroduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Openingapproximate
- 3E0K8GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0K8TZIntroduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0N7GCIntroduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Openingapproximate
- 3E0N7TZIntroduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Openingapproximate
- 3E0N8GCIntroduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0N8TZIntroduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0P3GCIntroduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approachapproximate
- 3E0P4GCIntroduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approachapproximate
- 3E0W3GCIntroduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approachapproximate
- 3E0W3TZIntroduction of Destructive Agent into Lymphatics, Percutaneous Approachapproximate
- XW03331Introduction of Idarucizumab, Dabigatran Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 1approximate
- XW033A3Introduction of Bezlotoxumab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 3approximate
- XW033F3Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 3approximate
- XW04331Introduction of Idarucizumab, Dabigatran Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 1approximate
- XW043A3Introduction of Bezlotoxumab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 3approximate
- XW043F3Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 3approximate
Common questions about 99.29
What is the ICD-10 code for ICD-9 99.29?
- The GEMs map 99.29 to ICD-10-PCS 3E013GC, 3E0333Z, 3E033FZ, 3E033HZ, 3E033KZ, 3E033RZ and 59 more.
GEMs are a translation aid, not a substitute for coding from the record. The 2027 ICD-10 code set has changed since the last GEMs release in 2018. Page updated September 29, 2026.